» Articles » PMID: 19269522

Barrett's Oesophagus

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2009 Mar 10
PMID 19269522
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Barrett's oesophagus is a metaplastic change of the lining of the oesophagus, such that the normal squamous epithelium is replaced by specialised or intestinalised columnar epithelium. The disorder seems to be a complication of chronic gastro-oesophageal reflux disease, although asymptomatic individuals might also be affected, and it is a risk factor for the development of oesophageal adenocarcinoma, a cancer with rapidly increasing incidence in developed societies. We review the presentation, epidemiology, and risk factors for this condition. We discuss the molecular changes necessary for the development of Barrett's oesophagus and its progression to cancer, and new strides in both the endoscopic detection of the lesion and the treatment of dysplastic disease. Also, we assess the effectiveness of efforts to screen patients at risk of Barrett's oesophagus, and whether such efforts avert cancer death. We conclude with a discussion of future directions for research, focusing on treatment of early neoplasia, and modifications of current practices to show our evolving understanding of this condition.

Citing Articles

Does radiofrequency ablation of the lower oesophagus allow for clonal expansion of highly mutated neosquamous epithelium?.

Akarca F, Shaheen N, Stachler M BMJ Oncol. 2025; 2(1):e000089.

PMID: 39886511 PMC: 11203143. DOI: 10.1136/bmjonc-2023-000089.


'Why Don't We Get Counselling?': Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses.

Davies E Cancer Med. 2025; 14(2):e70607.

PMID: 39812114 PMC: 11733675. DOI: 10.1002/cam4.70607.


Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

Laun S, Pierre F, Kim S, Lunz D, Maddala T, Braun J Diagnostics (Basel). 2024; 14(18).

PMID: 39335682 PMC: 11431466. DOI: 10.3390/diagnostics14182003.


Exploring the incidence of dysplasia or adenocarcinoma in early onset Barrett's esophagus.

Noordzij I, Huysentruyt C, Curvers W, van Lijnschoten G, Masclee A, Schoon E Endoscopy. 2024; 56(12):906-912.

PMID: 39313196 PMC: 11716541. DOI: 10.1055/a-2386-7843.


Reasons for fear of cancer recurrence after endoscopic treatment of T1 esophageal adenocarcinoma. A semi-structured interview study.

Rosmolen W, Pouw R, Bergman J, Sprangers M, Nieuwkerk P Dis Esophagus. 2024; 37(12).

PMID: 39169835 PMC: 11605615. DOI: 10.1093/dote/doae067.